首页> Investigative ophthalmology & visual science> Safety and long-term efficacy of AAV2-BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies

Safety and long-term efficacy of AAV2-BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies

导出原文传递

翻译打印收藏纠错

作者： Guziewicz, Karina E. ^[1] ; Cideciyan, Artur V. ^[2] ; Kendrick, Brian T. ^[3] ; Dufour, Valerie L. ^[4] ; Ruthel, Gordon ^[5] ; Komaromy, Andras M. ; Iwabe, Simone ; Hauswirth, William ; Beltran, William A. ; Jacobson, Samuel G. ; Aguirre, Gustavo D.

作者单位： Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA ^[1] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA ^[2] Univ Florida, Dept Ophthalmol, Gainesville, FL 32611 USA ^[3] Univ Penn, Clin Sci & Adv Med, Philadelphia, PA 19104 USA ^[4] Michigan State Univ, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA ^[5]

发布时间 2020-08-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Investigative ophthalmology & visual science

2019年60卷9期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and long-term efficacy of AAV2-BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies

Investigative ophthalmology & visual science

相似文献

Investigative ophthalmology & visual science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and long-term efficacy of AAV2-BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies

Investigative ophthalmology & visual science

相似文献

Investigative ophthalmology & visual science

相关期刊

检索历史清除